Across TCGA pan-cancer cohorts, WDR26 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated WDR26 data layer compared with 23 for mass-spec protein and 6 for mass-spec protein.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher WDR26 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated WDR26 expression acts as an unfavorable survival marker.
BLCA, COAD, and UCEC are the cancer types where WDR26 Mutation most reproducibly stratifies survival.